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Abstract
Activity-dependent transcription of brain-derived neurotrophic factor (BDNF) has been studied as an important model to
elucidate the mechanisms underlying numerous aspects of neuroplasticity. It has been extensively emphasized that Ca
2+
influx through different routes may have significantly different effects on BDNF transcription. Here, we examined the
regulatory property of the major calcium responsive elements (CaRE) in BDNF promoter IV in cultured rat cortical neurons.
BDNF promoter IV, as well as CaRE1 and CaRE3, was significantly activated by Ca
2+ influx through L-type voltage-gated
calcium channel (L-VGCC) or NMDA receptor (NMDAR). However, the L-VGCC- and NMDAR-mediated activation of CaRE was
differentially regulated by different Ca
2+-stimulated protein kinases. Specifically, PKA, CaMKI, and CaMKIV activity were
required for L-VGCC-, but not NMDAR-mediated CaRE1 activation. CaMKI activity was required for NMDAR- but not L-VGCC-
mediated CaRE3 activation. Surprisingly, the activation of CaRF, a previously identified transcription factor for CaRE1, was
stimulated via L-VGCC but not NMDAR, and required MEK, PI3K and CaMKII activity. These results suggest a new working
model that activity-dependent BDNF IV up-regulation may be coordinately mediated by CaRE1 and CaRE3 activity, which
show different responses to Ca
2+-stimulated kinases. Our data also explain how the individual cis-element in BDNF promoter
is distinctively coupled to different Ca
2+ routes.
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Introduction
Activity-dependent gene transcription is functionally relevant
for animals to acquire information and adapt to their environ-
ments. One major molecule that transduces neuronal activity and
regulates transcription is calcium. Ca
2+ influx through voltage-
gated and ligand-gated Ca
2+ channels triggers the activation of
multiple protein kinases, and subsequently regulates transcription
factors and transcription initiation.
Previous studies on transcription factor CREB (cAMP respon-
sive element binding protein) have revealed how transcription
initiation can be tightly and specifically controlled by multiple
signaling activities triggered by Ca
2+ [1,2,3]. Specifically, multiple
phosphorylation sites in CREB are regulated by calmodulin
(CaM)-dependent protein kinases, cAMP-dependent protein
kinase (PKA), and the Ras/Raf/MAPK/Rsk cascade. Further,
lack of CREB-mediated transcription is implicated in mental
disorders [4,5], neurodegeneration [6], apoptosis during develop-
ment [7,8], and impaired synaptic plasticity [9].
One important gene target of CREB is brain-derived neuro-
trophic factor (BDNF). BDNF transcription is very responsive to
neural activity. It is up-regulated by learning [10,11], physical
exercise [12], and kindling or kainite-induced seizures [13]. The
induction of BDNF expression could theoretically exert further
modification on synaptic functions, such as regulating dendritic
spine density [14,15], enhancing both pre-synaptic and post-
synaptic functions [16,17], and mediating long-term potentiation
(LTP) and memory formation [18,19].
Molecular studies have revealed that the BDNF gene consists of
nine 59 exons (from exon I to IXA) and a common 39 encoding
exon IX [20]. After transcription and splicing, one and only one 59
exon is joined to exon IX, resulting in nine different BDNF
mRNA forms, each of which contains one 59 exon and the exon
IX. In cultured cortical neurons, Ca
2+ influx through L-type
voltage-gated calcium channel (L-VGCC) and NMDA receptor
(NMDAR) specifically stimulates the transcription of exon IV-
containing BDNF mRNA or BDNF IV [21,22,23] (because of the
recent discovery of new exons, exon IV was described as exon III
in the earlier studies). The 1500 bp of the 59 flanking sequence of
exon IV (defined as promoter IV) confers the transcriptional
activity that is regulated by Ca
2+ stimulation [21]. Truncation and
mutagenesis analysis have identified three calcium responsive
elements, namely CaRE1, CaRE2, and CaRE3 [24,25]. By using
a yeast one-hybrid screening, transcription factors CaRF (Calcium
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been found to bind CaRE1 and CaRE2, respectively [24,25]. In
vitro and in vivo studies have demonstrated the binding of CREB to
CaRE3 [21,26]. Although it is well established that the activity-
dependent BDNF transcription depends on Ca
2+-stimulated
protein kinases, how Ca
2+ regulates the individual CaRE is not
known. In addition, although Ca
2+ influx through different routes
(e.g. through L-VGCC and NMDAR) may have significantly
different impacts on BDNF transcription [2], to our knowledge,
how Ca
2+ influx through L-VGCC and NMDAR could dictate
different regulation of BDNF transcription remains obscure.
To investigate these important issues, we used pharmacological
inhibition and dominant negative constructs of the major Ca
2+-
stimulated protein kinases to examine the regulation of BDNF
exon IV transcription, promoter IV activity, and CaRE activity in
cultured neurons. Our results suggest that the individual CaRE
coordinates with each other to regulate promoter IV activity. Our
data also demonstrated that the activity of CaRE was differentially
regulated by Ca
2+-stimulated protein kinases, and showed different
regulatory properties in response to Ca




All chemical reagents were purchased from Sigma (St. Louis,
MO), unless otherwise stated. LY294002 (a PI3K inhibitor),
PD98059 (a MEK inhibitor), and H89 (a PKA inhibitor) were
purchased from Calbiochem (Gibbstown, NJ). Oligonucleotides
were synthesized by Integrated DNA Technologies (Coralville,
IA). Cell culture and transfection reagents were from Invitrogen
(Carlsbad, CA).
Plasmids and reporter constructs
The 911 bp promoter IV region of BDNF was cloned from rat
genomic DNA with the specific forward primer (59-ATGCTC-
GAGAAGAGGCTGTGGCACCGTGC-39) and the reverse
primer (59-CCCAAGCTTTCCCCAAGGTTCTAGACTC-39).
The fragment was inserted into the XhoI/HindIII site of pGL3-
basic firefly luciferase reporter vector (Promega, Madison, WI) to
generate PIV-Luc. Three copies of CaRE1, or CaRE2, or CaRE3
[24] sequence in BDNF promoter IV were cloned into pGL3-
promoter firefly luciferase reporter vector, which contains a
minimal SV40 promoter, to generate plasmids CaRE1-Luc,
CaRE2-Luc and CaRE3-Luc. The CRE-Luc reporter plasmid
was described previously [27], and was a gift from Dr. Daniel
Storm (University of Washington). Gal4, Gal4-CaRF, Gal4-
CREB, and UAS-Luciferase constructs [24] were generously
provided by Dr. Michael Greenberg (Harvard University). The
Renilla Luciferase reporter construct, TK-pRL (Renilla-lucifer-
ase), was from Dr. Richard Miksicek (Michigan State University).
Expression plasmids of dominant negative PKA (dnPKA, which
harbors mutations at the cAMP binding sites) [27], dominant
negative MEK (dnMEK, which harbors a S222A mutation) [27],
dominant negative PI3K (dnPI3K, p110DKIN) [28], dominant
negative CaMKI (dnCaMKI, which harbors multiple mutations in
the catalytic residues, CaMKK phosphorylation domain, and the
autoinhibitory domain), dominant negative CaMKIV (dnCaM-
KIV, which harbors multiple mutations in the ATP binding sites
and the autoinhibitory domain with a nuclear localization signal
attached) [29], and CaMKIIN (which expresses a CaMKII
inhibitory protein) [30] were described previously. Dominant
negative calmodulin (pJPA7/rCaM-DEF1234A) [31] was from
Dr. Philippe Marin (University of Montpellier, France). Plasmid
expressing a constitutively active CREB (VP16-CREB, in which
the first Gln-rich domain of CREB is replaced by the transactiva-
tion domain of Herpes simplex virus VP16) [32] was from Dr.
Karl Obrietan (Ohio State University).
Primary culture of cortical neurons
The Institutional Animal Care and Use Committee at Michigan
State University have approved all the methods in this study. The
approval ID is 11/10-182-00. As described previously [33], brain
tissue was obtained from post-natal day 0 Sprague Dawley rats.
Dorsal and frontal cortical regions were dissected and incubated in
the digestion buffer containing 10 unit/ml papain (Worthington),
100 unit/ml DNase I (Roche), and 5 mg/ml cystine (Sigma) in
Hibernate A (BrainBits LLC). After 30 min digestion and
dispersion, neurons were seeded on poly-D-lysine (50 mg/ml,
Sigma, St. Louis, MO)-coated plates at a density of 0.15 million
cells/cm
2. The culturing medium was Neurobasal A with B27
supplement, penicillin/streptomycin, and 0.5 mM glutamate.
Neuronal stimulation
Ca
2+ influx through L-VGCC was triggered by membrane
depolarization with KCl (at 50 mM) treatment. Neurons were first
pre-treated with APV (100 mM) and CNQX (40 mM) for 30 min
before the addition of KCl. Ca
2+ influx through NMDA receptor
was triggered by NMDA (20 mM) and glycine (2 mM) treatment.
Neurons were first pre-treated with nifedipine (10 mM) and
CNQX (40 mM) for 30 min before adding NMDA/glycine.
APV, nifedipine, and CNQX were used to block NMDAR, L-
type voltage-gated calcium channel, and non-NMDA type
glutamate receptors, respectively. To inhibit MEK, PI3K, PKA,
and CaMKs, neurons were pre-treated for 30 min before
stimulation with PD98059 (50 mM), LY294002 (30 mM), H89
(10 mM), and KN93 (5 mM), respectively. To stop transcription, a
transcription inhibitor actinomycin D (ACD) was used at a
concentration of 100 ng/ml. The stimulation or inhibition was
done by adding the drugs directly into the culture medium.
Real-time PCR
Neurons were treated on 14 days in vitro (DIV). After stimulation
with KCl or NMDA, control and stimulated neurons were lysed.
Total RNA was extracted with TRIzol (Invitrogen). RNA
concentration was measured by NanoDrop 1000 (Thermo,
Waltham, MA), and 0.5 mg RNA was reverse transcribed to
cDNA with the SuperScript III kit (Invitrogen). Exon IV-
containing BDNF (BDNF IV) mRNA and GAPDH mRNA were
amplified by the iQ SYBR Green real-time PCR system (Bio-Rad,
Hercules, CA), and analyzed with the 2
2DDCt method by
normalizing BDNF IV signal to GAPDH. The annealing
temperature for both genes was 55uC. The primers were 59-
CTCCGCCATGCAATTTCCAC-39 and 59-GCCTTCATGCA-
ACCGAAGTA-39 for BDNF exon IV. Primers 59-TCCATGA-
CAACTTTGGCATTGTGG-39 and 59-GTTGCTGTTGAA-
GTCGCAGGAGAC-39 were used to amplify GAPDH. All real-
time PCR measurements of Exon IV mRNA were done 1 h after
stimulation, because our preliminary data showed that the
endogenous mRNA transcription reached the peak value at 1 h
and remained constant for at least 3 hours.
Transfection and luciferase assay
Cultured neurons were transfected on 9 DIV by using
Lipofectamine 2000 (Invitrogen). Following manufacturer’s in-
struction, 0.1 mg luciferase reporter plasmid (or 0.1 mg Gal4 and
0.1 mg UAS-Luc) and 0.4 mg Renilla-luc plasmid were mixed with
Regulation of BDNF Transcription by Ca
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experiments, neurons were also co-transfected with constructs that
express regulatory proteins (such as dominant negative protein
kinases). Forty-eight hours after transfection (i.e. on 11 DIV),
neurons were stimulated by KCl or NMDA for 6 hours. Cells
were lysed and the Luciferase activity of the lysate was analyzed
with the Dual-Glo Luciferase Assay System (Promega) according
to the manufacturer’s instruction. The luciferase activity was
measured by a Veritas Microplate Luminometer. Firefly luciferase
activity was normalized to Renilla luciferase activity. The activity
of luciferase reporter plasmids (such as CaRE1, CaRE2, and
CaRE3) was compared to that of pGL3-SV40-luciferase. All
luciferase assays were done 6 hours after stimulation, because,
consistent with previous studies, significant luciferase up-regulation
was observed between 4 to 6 hours. Because the transfection
efficiency was higher with DIV 9 neurons, all the luciferase
experiments were done with DIV 11 neurons (i.e. 2 days after
transfection).
Western blotting
Neurons on 14 DIV were pretreated with inhibitors for
30 minutes, followed by a 20-minute KCl stimulation. Neuron
samples were then harvested in SDS lysis buffer (10 mM Tris–HCl
buffer, 10% glycerol, 2% SDS, 0.01% bromophenol blue, and 5%
b-mercaptoethanol, pH 6.8), and proteins were separated with
SDS-PAGE (Invitrogen). Separated proteins were transferred onto
a nitrocellulose membrane, incubated with specific primary
antibodies (1:1000 dilution for anti-pERK1/2 and 1:5000 dilution
for anti-b-actin, Cell Signaling, MA), and then incubated with
horseradish peroxidase (HRP)-labeled secondary antibodies (1:
5000 for both goat anti-rabbit IgG and goat anti-mouse IgG,
Thermo). The signal was detected by an enhanced chemilumi-
nescence system (Thermo). The signal intensity was determined by
Scion Image software (Scion Corp. Frederick, Maryland). The
pERK1/2 level was normalized to b-actin.
Data analysis
All results were presented as average 6 SEM. Student’s t-test
(unpaired) was used for comparison between two groups. One-way
ANOVA and LSD post hoc analysis were used for comparisons
among multiple groups. The difference is considered as statistically
significant when p,0.05 is reached.
Results
Regulation of BDNF exon IV transcription through
promoter IV
Previous studies have demonstrated that the route of Ca
2+ influx
matters for the activity-dependent gene transcription of BDNF
exon IV. Because co-application of nifedipine and APV ablates
KCl-stimulated exon IV transcription, it was concluded that
membrane depolarization triggers transcription through L-VGCC
and NMDAR. Here, we examined L-VGCC-mediated transcrip-
tion by co-application of KCl with NMDAR antagonist APV. The
NMDAR-mediated transcription was stimulated by co-application
of NMDA and L-VGCC antagonist nifedipine. In both cases, we
included CNQX to block non-NMDA type glutamate receptors.
First, as shown in Figure 1A and 1B, robust up-regulation of
exon IV-containing BDNF mRNA was stimulated by KCl or
NMDA in DIV 14 cortical neurons. The KCl-induced BDNF IV
Figure 1. KCl and NMDA stimulate BDNF IV mRNA transcription and PIV-luciferase activity through L-VGCC and NMDAR. For (A) and
(B), DIV 14 cortical neurons were treated with 50 mM KCl (A) or 20 mM NMDA (B) for one hour. L-VGCC blocker nifedipine (10 mM), or NMDAR
antagonist APV (100 mM), or extracellular calcium chelator EGTA (2.5 mM) was added 30 min before the stimulation. After the one-hour incubation
with NMDA or KCl, samples were collected and total RNA was extracted. The extracted RNA was reverse transcribed to cDNA, and then analyzed by
real-time PCR. The level of BDNF IV mRNA was normalized to that of GAPDH mRNA. For (C) and (D), DIV 9 cortical neurons were transfected with
promoter IV-luciferase reporter and TK-pRL plasmid. Two days after transfection (i.e. on DIV 11), neurons were treated with 50 mM KCl (C) or 20 mM
NMDA (D). To pharmacologically block L-VGCC, or NMDAR, or chelate extracellular calcium, neurons were pre-treated with nifedipine, or APV, or
EGTA, respectively. After six-hour incubation with KCl or NMDA, dual luciferase assay was performed. The firefly luciferase activity was normalizedt o
Renilla-luciferase. In the left panels, ‘‘*’’ indicates statistical difference to all other groups, and ‘‘#’’ indicates significant difference to the naı ¨ve group
not treated with any drug. In the right panels, the effect of drugs on KCl- or NMDA-stimulated fold induction of transcription was normalized to the
drug-only group (*: statistically different to that of the KCl- or NMDA-stimulated transcription in neurons not treated with nifedipine, or APV, or EGTA).
Data were collected from 4 independent preparations for each treatment. All neurons in A and C were pre-treated with CNQX and APV. All neurons in
B and D were pre-treated with CNQX and nifedipine.
doi:10.1371/journal.pone.0028441.g001
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nifedipine (Figure 1A), whereas the NMDA-induced BDNF IV
up-regulation was abolished by the NMDAR antagonist APV
(Figure 1B). These data indicate that the induction by KCl and
NMDA is mediated through the activation of L-VGCC and
NMDAR, respectively. Second, the L-VGCC- and NMDAR-
mediated increase of BDNF IV mRNA was abolished by inclusion
of calcium chelator EGTA in the culture medium, demonstrating
the role of extracellular calcium and calcium influx (Figure 1A and
B). We also found that the spontaneous activity of NMDAR but
not L-VGCC might be involved in maintaining the basal
transcription of BDNF IV in non-stimulated neurons. As shown
in Figure 1B, in neurons pre-treated with CNQX and nifedipine,
blocking NMDAR with APV significantly reduced the level of
exon IV-containing mRNA (p,0.05). In contrast, blocking L-
VGCC with nifedipine only slightly (without any statistical
significance) reduced exon IV (Figure 1A).
By using pharmacological inhibitors, we blocked several Ca
2+-
stimulated protein kinases, which have been implicated to regulate
CREB activity. Inhibition of MEK (by PD98059) suppressed both
basal and L-VGCC- or NMDAR-mediated transcription
(Figure 2A and 2B, upper panels). After normalization to the
exon IV mRNA level in neurons treated only with PD98059, KCl
or NMDA (in the presence of PD98059) stimulated significantly
less transcription of exon IV (Figure 2A and 2B, lower panels).
Although KCl and NMDA stimulated significant exon IV
transcription in the presence of PI3K and PKA inhibitor
(Figure 2A and 2B, upper panels), the induction fold of exon IV
mRNA increase was significantly less than that in neurons not
treated with these inhibitors (Figure 2A and 2B, lower panels). Our
result suggests that the MEK-ERK1/2 signaling may also be
required for the promoter IV-mediated transcription driven by
spontaneous activity in resting neurons. The effects of Ca
2+ influx
and the inhibitors on the mRNA level of exon IV were mainly due
to transcription rather than altering mRNA stability, because there
was no significant changes in neurons treated with transcription
inhibitor actinomycin D (ACD) (Supplemental Figure S1A and
S1B).
Cloning of the 911 bp 59 flanking sequence of exon IV showed
that this region is responsible for the Ca
2+-stimulated promoter
activity [21]. Here, we sought for further evidence that this
flanking sequence is a bona fide promoter for exon IV. We found
that the luciferase activity driven by promoter IV (PIV) was
stimulated by both L-VGCC and NMDAR in a calcium-
dependent manner (Figure 1C and 1D). The level of PIV activity
in non-stimulated neurons was affected by APV but not by
nifedipine, consistent with what was observed for exon IV mRNA
(as shown in Figure 1A and B). Further, pharmacological
inhibition of PI3K and PKA suppressed PIV activity in both
KCl- and NMDA-stimulated neurons without affecting the basal
level (Figure 2C and 2D). In agreement with the function of MEK-
ERK1/2 in regulating basal exon IV mRNA level, acute
treatment with PD98059 also suppressed PIV-luciferase activity
in non-stimulated neurons (Figure 2C and 2D, upper panels). After
normalization to the luciferase activity in PD98059-treated
neurons, KCl or NMDA (in the presence of PD98059) stimulated
significantly less PIV-driven luciferase expression (Figure 2C and
2D, lower panels).
We next tested the function of these Ca
2+-regulated protein
kinases by co-transfecting their dominant negative (dn) constructs
with PIV-luciferase. We found that dnMEK, dnPI3K, and dnPKA
suppressed the up-regulation of PIV activity in both KCl- and
NMDA-stimulated neurons without significantly changing its basal
level activity (Figure 2E and 2F). Because the MEK activity was
suppressed for about 48 hours in neurons transfected with
dnMEK, there might be some compensatory effects to counteract
its regulation of the basal PIV activity.
We next examined the function of calmodulin (CaM)-depen-
dent protein kinases. CaMKI, II, and IV, which have been
implicated in regulating synaptic plasticity and gene transcription
[34], are abundant in the central nervous system. Neurons treated
with KN93, which is a robust inhibitor for CaMKI, II, and IV,
showed lower basal level of exon IV mRNA (Figure 3A and 3B)
and PIV activity (Figure 3C and 3D). In the presence of KN93,
KCl failed to stimulate PIV and exon IV transcription (Figure 3A
and 3C), and the NMDA-induced stimulation was significantly
suppressed (Figure 3B and 3D). Blocking CaM or CaMKI activity
by dnCaM or dnCaMKI, respectively, blocked both basal and Ca-
stimulated (by KCl or NMDA) PIV activity (Figure 3E and 3F).
Overexpression of dn constructs of CaMKII and CaMKIV
suppressed both KCl- and NMDA-induced PIV activity without
affecting the basal levels (Figure 3E and 3F). Because KN93 did
not affect the level of exon IV-containing mRNA in the presence
of transcription inhibitor ACD (Supplemental Figure S1A), it
suggests that the CaM kinases mainly regulate transcription rather
than exon IV mRNA stability. These data demonstrate the
function of the major Ca
2+-stimulated protein kinases in regulating
BDNF transcription through the 911 bp 59 flanking sequence.
Regulation of CaRE1 and CaRE3 activity by calcium influx
through L-VGCC and NMDAR
Three calcium responsive elements (CaRE) have been identified
within the 170 bp 59 flanking region of exon IV (see Figure 4A).
Previous studies have demonstrated that membrane depolarization
stimulates CaRE1 activity through L-VGCC [24,25]. Mutation of
CaRE2 and CaRE3 in the context of the 170 bp sequence
suppressed KCl-induced transcription. Here, we found that
CaRE1-mediated transcription was up-regulated by the activation
of both L-VGCC and NMDAR (Figure 4B). For CaRE2, we did
not observe any significant stimulation by either L-VGCC or
NMDAR (Figure 4C). Next, we found that Ca
2+ influx through
either L-VGCC or NMDAR stimulated CaRE3-mediated tran-
scription (Figure 4D).




2+ influx stimulated significant CaRE1 activity, the
regulatory mechanism is unknown. As described earlier, we found
that both exon IV transcription and PIV activity were regulated by
the major Ca
2+-regulated protein kinases, including MEK, PI3K,
PKA and CaMKs. Here, we sought to determine the regulatory
property of the individual CaRE. We found that inhibition of
MEK and PI3K (by dnMEK and dnPI3K) suppressed both basal
level and KCl- or NMDA-stimulated CaRE1 activity (Figure 5A
and 5B). While inhibition of PKA activity by overexpressing
dnPKA suppressed KCl-induced up-regulation of CaRE1-medi-
ated transcription without affecting the basal level, PKA activity
was not required for NMDA-stimulated CaRE1 up-regulation
(Figure 5A and 5B).
It has been shown that CaM physically interacts with L-VGCC,
and the interaction may be functionally important for signal
propagation [35]. As for the function of NMDAR-mediated
intracellular signaling, physical interaction between CaMKII and
NMDAR may be significant for signaling triggered by NMDAR-
mediated Ca
2+ influx [34]. Here, we found that inhibition of CaM
by dnCaM, as well as inhibition of CaMKI, II, and IV by
overexpressing their dn constructs, suppressed the basal level of
Regulation of BDNF Transcription by Ca
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28441Figure 2. Promoter IV activity correlates with the transcription profile of exon IV-containing BDNF mRNA. For (A) and (B), DIV 14
cortical neurons were stimulated by 50 mM KCl (A) or 20 mM NMDA (B). To block the activity of MEK, PI3K, and PKA, neurons were pre-treated with
their inhibitors (i.e. PD98059, LY294002, and H89, respectively) for 30 min before stimulation. After the one-hour incubation with KCl or NMDA,
neuron samples were collected and total RNA was extracted. The extracted RNA was reverse transcribed to cDNA, and then analyzed by real-time
PCR. The level of BDNF IV mRNA was normalized to that of GAPDH mRNA. From C to F, DIV 9 cortical neurons were transfected with promoter IV-
luciferase reporter plus TK-pRL (C and D), or co-transfected with promoter IV-luciferase/TK-pRL and dominant negative constructs of MEK, PI3K, and
PKA (E and F). Two days after the transfection (i.e. on DIV 11), neurons were treated with 50 mM KCl (C and E) or 20 mM NMDA (D and F). To
pharmacologically block MEK, PI3K, and PKA, neurons were pre-treated with their inhibitors (i.e. PD98059, LY294002, and H89, respectively) for
Regulation of BDNF Transcription by Ca
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panels). Although KCl simulated significant up-regulation of
CaRE1-mediated transcription in the presence of these dn
constructs (Figure 6A, left panel), the induction fold was
significantly less (Figure 6A, right panels). The requirement of
CaMKI and IV was specific for L-VGCC-mediated CaRE1 up-
regulation, because dnCaMKI and dnCaMKIV failed to suppress
NMDAR-mediated CaRE1 up-regulation (Figure 6B, right panel).
In contrast, inhibition of CaMKII by overexpressing CaMKIIN
suppressed both L-VGCC- and NMDAR-mediated CaRE1 up-
regulation (Figure 6A and 6B, right panels). These data post an
interesting possibility that CaRE1 activity is distinctively coupled
to different Ca
2+ routes (i.e. L-VGCC and NMDAR) via different
protein kinases (e.g. PKA, CaMKI, and CaMKIV).
Regulation of CaRE3-mediated transcription by
Ca
2+-stimulated protein kinases
As shown in Figure 4D, we observed that CaRE3 activity was
stimulated by both L-VGCC- and NMDAR-mediated Ca
2+
influx. We further examined how Ca
2+-activated protein kinases
regulate its activation. We found that inhibition of these Ca
2+-
stimulated protein kinases did not affect the basal activity of
CaRE3 in non-stimulated neurons. In KCl-stimulated neurons,
overexpression of dnPKA, dnCaM, and dnCaMKIV abolished L-
VGCC-mediated activation of CaRE3 (Figure 5C and 6C, left
panels). The induction fold of L-VGCC-mediated CaRE3
activation was significantly suppressed by dnMEK and dnPI3K,
but not by dnCaMKI and CaMKIIN (Figure 5C and 6C, right
panels).
30 min before stimulation (C and D). After the six-hour incubation with KCl or NMDA, dual luciferase assay was performed. The firefly luciferase
activity was normalized to Renilla-luciferase. In the upper panels, ‘‘#’’ indicates significant difference to the naı ¨ve group not treated with any inhibitor
or stimulator. In the lower panels, the effect of protein kinase inhibitors or dn constructs on KCl- or NMDA-stimulated transcription was normalized to
the inhibitor-only or dn construct-only group (*: statistically different to that of the KCl- or NMDA-stimulated transcription in neurons not treated with
any protein kinase inhibitor or dn construct). Data were collected from 3 (for A and B) or 8 (from C to F) independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g002
Figure 3. Promoter IV activity is regulated by calmodulin (CaM)-dependent protein kinases I, II, and IV (CaMKI, II, and IV). For (A) and
(B), DIV 14 neurons were treated with KN93 for 30 min before stimulation (50 mM KCl in A or 20 mM NMDA in B) to block the activity of CaMKI, II, and
IV. Real-time PCR was performed to measure BDNF IV mRNA, which is normalized to GAPDH. For (C) to (F), DIV 9 cortical neurons were transfected
with promoter IV-luciferase reporter plus TK-pRL (C and D) or co-transfected with promoter IV-luciferase/TK-pRL and dominant negative construct of
CaM, CaMKI, CaMKIV, and CaMKIIN (E and F). Two days after the transfection (i.e. on DIV 11), neurons were treated with 50 mM KCl (C and E) or 20 mM
NMDA (D and F). In C and D, KN93 was applied 30 min before stimulation. After the six-hour incubation with KCl or NMDA, dual luciferase assay was
performed. The firefly luciferase activity was normalized to Renilla-luciferase. In the left panels, ‘‘#’’ indicates significant difference between the
inhibitor/dn construct group and the naı ¨ve group not treated with any drug or the dn construct; ns indicates no statistical difference. In the right
panels, the effect of protein kinase inhibitors or dn constructs on KCl- or NMDA-stimulated transcription was normalized to the inhibitor-only or dn
construct-only group (*: statistically different to that of the KCl- or NMDA-stimulated transcription in neurons not treated with any protein kinase
inhibitor or dn construct). Data were collected from 8 independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g003
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28441Figure 4. CaRE1 and CaRE3, but not CaRE2 activity, are stimulated by calcium influx. (A) Schematic illustration of the relative positions of
CaRE1, 2, and 3 in the promoter IV region of BDNF gene. These calcium responsive elements are binding sites for transcription factors CaRF, USF, and
CREB. The nucleotide sequences of CaRE1, 2, 3, and CRE are also shown. From (B) to (D), cortical neurons at DIV 9 were transfected with CaRE1, or 2, or
3-luciferase reporter constructs plus TK-pRL. As a control, the backbone construct (SV40-luciferase) and TK-pRL were co-transfected for normalization
purposes. On DIV 11, neurons were treated with 50 mM KCl or 20 mM NMDA. Dual luciferase assay was performed after the six-hour incubation with
KCl or NMDA. Neurons used for KCl treatments (both the control and the stimulated groups) were pre-treated with APV and CNQX to block NMDAR
and non-NMDA type glutamate receptors, respectively. Neurons used for NMDA treatment (both the control and the stimulated groups) were pre-
treated with nifedipine and CNQX to block L-VGCC and non-NMDA type glutamate receptors, respectively. The firefly luciferase activity was
normalized to Renilla-luciferase. Then, CaRE-mediated activity was normalized with SV40 activity. SV40 activity was obtained from neurons co-
transfected with SV40-luc and TK-pRL. ns: not statistically significant between stimulated and control neurons. For all experiments in this figure, data
were collected from 16 independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g004
Figure 5. Regulation of Ca
2+-stimulated CaRE1 and CaRE3 activity by MEK, PI3K, and PKA. DIV 9 cortical neurons were transfected with
CaRE1-Luc (A and B) or CaRE3-Luc (C and D) plus TK-pRL and dominant negative MEK, PI3K, and PKA as indicated. For the normalization purpose,
SV40-luciferase plus TK-pRL and dominant negative MEK, PI3K and PKA were transfected into different sets of neurons. On DIV 11, neurons were
treated with 50 mM KCl (A and C) or 20 mM NMDA (B and D). Dual luciferase assay was performed after the six-hour incubation with KCl or NMDA.
After normalized to Renilla luciferase activity, CaRE1- or CaRE-3 activity was further normalized to SV40 activity, and expressed as relative values. In
the left panels, ‘‘#’’ indicates significant difference between neurons expressing dn construct and the naı ¨ve neurons without dn construct; ns
indicates no statistical difference. In the right panels, the effect of dn construct on KCl- or NMDA-stimulated transcription was normalized to the dn
construct-only group (*: statistically different to that of the KCl- or NMDA-stimulated transcription in neurons not expressing any dn construct). For all
experiments in this figure, data were collected from 12 independent preparations for each experiment.
doi:10.1371/journal.pone.0028441.g005
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activation of CaRE3 was also differentially regulated. Although
MEK, PI3K, and PKA activity were required for both KCl- and
NMDA-stimulated CaRE3 activity (Figure 5C and 5D), CaM and
CaMKs were differentially required. The activity of CaRE3 was
stimulated by NMDA but not by KCl in neurons overexpressing
dnCaM and dnCaMKIV (Figure 6C and 6D, left panels). The full
activation of CaRE3-mediated transcription was suppressed by
dnCaMKI and dnCaMKIV but not by CaMKIIN in NMDA-
stimulated neurons (Figure 6D, right panel). In contrast, the L-
VGCC-mediated activation of CaRE3 required CaMKIV but not
CaMKI and CaMKII (Figure 6C, right panel). Consistent with the
finding of CaRE1, these data further suggest how Ca
2+ influx
through different routes could exert distinctive effects on the




2+-stimulated activation of CRE and CaRE3 requires
the same protein kinases
The DNA sequence of CaRE3 is similar to that of CRE
consensus sequence (Figure 4A). Previous results have also
demonstrated CREB binding to the CaRE3 sequence [21,26].
However, there is a possibility that the transcription complex
(possibly containing multiple regulators along with CREB) may
assemble differently at CaRE3 compared to the classical CRE.
Therefore, we decided to further examine whether CRE and
CaRE3 are regulated similarly by the major Ca
2+-activated
protein kinases.
Here, we found that the full-scale of Ca
2+-stimulated up-
regulation of CRE required the same set of Ca
2+-activated
protein kinases as those regulating CaRE3. Specifically, both L-
VGCC- and NMDAR-mediated CRE activation were sup-
pressed by dnMEK, dnPI3K, and dnPKA (Figure 7A and 7B,
right panels). CaM-mediated signaling was also required,
because overexpression of dnCaM suppressed L-VGCC- and
NMDAR-mediated CRE activation (Figure 7C and 7D, right
panels). In KCl-stimulated neurons, overexpression of dnCaM-
KIV, but not dnCaMKI or CaMKIIN, suppressed CRE-
mediated luciferase expression (Figure 7C, right panel). In
contrast, the NMDAR-mediated CRE activation was suppressed
by dnCaMKI and dnCaMKIV, but not by CaMKIIN
(Figure 7D, right panel).
We further tested whether the activation of CREB could
stimulate PIV and its calcium responsive elements. As shown in
Figure 8A, overexpression of a constitutively active form of CREB
(VP16-CREB, which confers transcription factor activity in the
absence of upstream CREB activators) significantly enhanced
PIV- and CRE-mediated transcription. Consistent with the
hypothesis that CaRE3 is a potential CRE, overexpression of
VP16-CREB also enhanced CaRE3-mediated transcription
(Figure 8B). In contrast, activation of CREB was not sufficient
to stimulate CaRE1 activity (Figure 8B).
Although these data demonstrate that both CRE and CaRE3
are regulated by CREB, we found that their regulatory property
was not identical. Specifically, KCl stimulated CRE but not
CaRE3 activity in neurons expressing dnPKA (Figure 5C and 7A,
left panels), dnCaM, and dnCaMKIV (Figure 6C and 7C, left
panels). Additionally, inhibition of PKA by dnPKA only abolished
CaRE3 activation but allowed partial CRE activation in NMDA-
stimulated neurons (Figure 5D and 7B, left panels).
Figure 6. Regulation of Ca2+-stimulated CaRE1 and CaRE3 activity by CaM-dependent kinase I, II, and IV. DIV 9 cortical neurons were
transfected with CaRE1-Luc (A and B) or CaRE3-Luc (C and D) plus TK-pRL and dominant negative CaM, CaMKI, CaMKIV, and CaMKIIN. For the
normalization purpose, SV40-luciferase plus TK-pRL and dnCaM, dnCaMKI, dnCaMKIV and CaMKIIN were transfected into another set of neurons. Two
days after transfection, neurons were treated with 50 mM KCl (A and C) or 20 mM NMDA (B and D), and analyzed by dual luciferase assay after the six-
hour incubation with KCl or NMDA. After normalized to Renilla luciferase activity, CaRE1 or CaRE3 activity was further normalized to SV40 activity, and
expressed as relative values. In the left panels, ‘‘#’’ indicates significant difference between neurons expressing dn construct and the naı ¨ve neurons
without dn construct; ns indicates no statistical difference. In the right panels, the effect of dn construct on KCl- or NMDA-stimulated transcription
was normalized to the dn construct-only group (*: statistically different to that of the KCl- or NMDA-stimulated transcription in neurons not
expressing any dn construct). For all experiments in this figure, data were collected from 12 independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g006
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Ca
2+-stimulated protein kinases
Calcium responsive factor (CaRF) has been identified as a
putative transcription factor for CaRE1, because it directly binds
CaRE1 in vitro [24]. We sought to understand how CaRF-
mediated transcription is regulated. We transfected neurons with a
plasmid expressing a fusion protein consisting of the DNA binding
domain of Gal4 and the transcriptional activation domain of
CaRF together with Gal4-UAS-driven luciferase reporter con-
struct. Thus we could measure CaRF transcriptional activity
through luciferase assay. Surprisingly, Gal4-CaRF activity was
only induced by KCl but not NMDA (Figure 9A). In contrast,
Gal4-CREB activity was significantly increased by both KCl and
NMDA (Figure 9B). Further, the regulatory property of CaRF was
different from that of CaRE1. The L-VGCC-mediated activation
of Gal4-CaRF was blocked by dnMEK, dnPI3K, dnCaM, and
CaMKIIN (Figure 9C and 9D). Although dnPKA caused
significant decrease in basal activity of CaRF (Figure 9C, left
panel), the induction fold of KCl-induced activation was intact in
neurons expressing dnPKA (Figure 9C, right panel). These data
suggest that the regulation of CaRF is different from that of
CaRE1. Other mechanisms, such as how binding of CaRF to
CaRE1 is regulated, may be involved.
Involvement of cross-talk between Ca
2+-stimulated
protein kinase pathways
It has been suggested that calcium-sensitive kinases may
regulate each other. We focused on MAPK pathway, which has
been found to be regulated by other signal transduction pathways
[25,36]. The level of phospho-ERK1/2, which is correlated with
ERK1/2 activation, was up-regulated by activation of L-VGCC.
Both the basal level and the KCl-induced activation were
suppressed by PI3K inhibitor LY294002, PKA inhibitor H89,
and CaMK inhibitor KN93 (Figure 10A and 10B). These data
confirmed that ERK1/2 activity was significantly disrupted when
PI3K, PKA and CaMKs were inhibited.
Because blocking a single pathway showed partial inhibitory
effects on PIV-mediated transcription (some inhibitor+stimulator
groups still showed significant induction over the corresponding
inhibitor-only groups), we tested whether further inhibition could
be achieved by simultaneously blocking multiple pathways.
Indeed, co-treatment with 2 inhibitors (as indicated in
Figure 10C) caused further more inhibition when compared to a
single inhibitor. Interestingly, the CaMKs may play a more
dominant role than other kinases. As shown in Figure 3A, KN93
totally abolished L-VGCC-stimulated BDNF IV mRNA up-
regulation. KN93 also showed more dramatic inhibition of KCl-
induced PIV activity (Figure 3C and 10C). Application of more
inhibitors (i.e. H89, PD98059, and LY294002) along with KN93
did not cause further inhibition (Figure 10C).
Discussion
Many aspects of brain function require activity-dependent
modifications of gene transcription. Ca
2+ influx mediated by
ligand- and voltage-gated Ca
2+ channels has been demonstrated as
an important molecular trigger for the activation of Ca
2+-
stimulated signaling cascade, which, in turn, turns on gene
transcription. BDNF transcription has been studied as a model to
delineate how Ca
2+-stimulated protein kinases regulate the activity
of its promoter through the coordination of multiple cis-elements
and trans-factors [21,24,25]. The main findings of this study are: 1)
the activation of CaRE by Ca
2+ influx through different routes (L-
VGCC and NMDAR) is mechanistically different and involves
different Ca
2+-activated protein kinases, 2) CaRE1 and CaRE3
Figure 7. Regulation of CRE by Ca
2+-stimulated protein kinases. The CRE-luciferase reporter construct plus TK-pRL along with the dominant
negative construct of Ca
2+-stimulated protein kinases (dnMEK, dnPI3K, and dnPKA for A and B; dnCaM, dnCaMKI, CaMKIIN, and dnCaMKIV for C and
D) were transfected into cortical neurons on DIV 9. SV40-luciferase plus TK-pRL along with different dominant negative construct were transfected
into another set of neurons for normalization purposes. On DIV 11, neurons were treated with 50 mM KCl (A and C) or 20 mM NMDA (B and D). Dual
luciferase assay was performed after the six-hour incubation with KCl or NMDA. After normalized to Renilla luciferase activity, CRE activity was further
normalized to SV40 activity, and expressed as relative values. In the right panels, the effect of dn construct on KCl- or NMDA-stimulated transcription
was normalized to the dn construct-only group (*: statistically different to that of the KCl- or NMDA-stimulated transcription in neurons not
expressing any dn construct). Data were collected from 8 independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g007
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different regulatory property from CaRE1, and is only sensitive to
Ca
2+ influx through L-VGCC.
It has been shown that Ca
2+-activated BDNF exon IV
transcription is mainly mediated by L-VGCC but not NMDAR
[37]. We and others have found that NMDA stimulation can
stimulate robust CREB activation and exon IV transcription in
younger (e.g. on DIV 3 to 7) but not in mature neurons (e.g. on
DIV 14) [22,38,39]. Compared to DIV 3–7 neurons, the total
expression of NMDAR is higher on DIV 14. Therefore, the same
concentration of NMDA (e.g. 50 mM) may cause proper NMDAR
activation in DIV 3 neurons, but lead to pathological over-
activation and shut off the pro-survival CREB-BDNF signaling in
DIV 14 neurons. It was further suggested that deactivation of
CREB and BDNF transcription may be mediated by the
activation of extrasynaptic NMDARs, because activation of
synaptic NMDARs alone always activate CREB and CRE-
mediated transcription [40]. It has been shown that lowering the
concentration of NMDA significantly stimulates CREB activity
and BDNF transcription, and is neural protective [41]. Here, we
show that NMDAR-mediated up-regulation of exon IV transcrip-
tion, as well as PIV, CaRE1, and CaRE3 activity, was significant
in mature neurons stimulated with 20 mM NMDA. We also
confirmed that the induction by NMDA was through NMDAR
and required extracellular calcium.
Although it has been postulated that the property of activity-
dependent BDNF IV transcription depends on the route of Ca
2+
entry [42,43], how different Ca
2+ routes dictate different responses
remains unclear. This study provides evidence that distinctive
Ca
2+-stimulated protein kinases are differentially required to
regulate the activity of the individual CaRE in a Ca
2+ route-
specific manner. It is intriguing that PKA is specifically required
for L-VGCC- but not NMDAR-stimulated CaRE1 activation.
Previous studies have demonstrated that L-VGCC and NMDAR
interact with different intracellular signaling molecules. For
Figure 8. Constitutively active CREB enhances CaRE3 but not
CaRE1 activity. (A) Promoter IV- or CRE-luciferase reporter construct
was co-transfected with TK-pRL and VP16-CREB expression plasmid into
DIV 9 neurons. (B) CaRE1- or CaRE3-luciferase reporter construct was co-
transfected with TK-pRL and VP16-CREB expression plasmid into DIV 9
neurons. The activity of promoter IV, CRE, CaRE1, and CaRE3 was
determined by dual luciferase assay on DIV 11. After normalized to
Renilla luciferase activity, CRE, or CaRE1 or CaRE3 activity was further
normalized to SV40 activity in neurons transfected with SV40-luciferase,
TK-pRL, and VP16-CREB. ns: not statistically significant. Data were
collected from 5 independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g008
Figure 9. Regulation of CaRF-mediated transcription by Ca
2+-stimulated protein kinases. Neurons on DIV 9 were transfected with Gal4
only, or Gal4-CaRF, or Gal4-CREB together with Gal4-UAS-Luc and TK-pRL. After 48 hours, the neurons were treated with 50 mM KCl (A) or 20 mM
NMDA (B) for 6 hours, and examined by luciferase assay. Dominant negative MEK, PI3K, and PKA (C), or CaM, CaMKI, CaMKIV, and CaMKIIN (D) were
co-transfected with the reporter constructs. The data was normalized to TK-Renilla luciferase activity, and then Gal4-CaRF or Gal4-CREB activity was
normalized to neurons transfected with Gal4 only. ns: not statistically different. In the left panels of C and D, ‘‘#’’ indicates significant difference
between neurons expressing dn construct and the naı ¨ve neurons without dn construct. In the right panels of C and D, the effect of dn construct on
KCl-stimulated transcription was normalized to the dn construct-only group (*: statistically different to that of KCl-stimulated transcription in neurons
not expressing any dn construct). Data were collected from 12 independent preparations for each treatment.
doi:10.1371/journal.pone.0028441.g009
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AKAP (AKAP15 and AKAP79/150) [44,45] and CaM may
provide a tighter coupling between PKA and CaRE1-mediated
transcription.
It has been shown that mutation in CaRE1, 2, and 3 disrupts
KCl-induced BDNF IV transcription [21,24,25]. We found that,
surprisingly, activation of NMDAR or L-VGCC only stimulated
CaRE1 and CaRE3 but not CaRE2. It has been reported that
CaRE2 is bound by USF1/2, and a consensus USFBE (USF
binding element) activity is triggered by membrane depolarization
but not by glutamate stimulation [25]. Our results indicate that
CaRE2 activity is different from the classical USFBE. Moreover,
the previous study stimulated DIV 5 neurons with KCl in the
absence of CNQX and APV, whereas we used more mature
neurons at DIV 11. We also excluded the involvement of
glutamate receptors by co-treatment with CNQX and APV along
with KCl. It is possible that CaRE2-mediated transcription is
developmentally regulated. Indeed, we were able to detect KCl-
mediated CaRE2 activation in DIV 5 neurons (data not shown).
Future effort should be made to examine how CaRE2-mediated
transcription is regulated in developing neurons.
Studies on the somatostatin promoter have identified a CRE
sequence 59-TGACGTCA-39, which is stimulated by the elevation
of cAMP and PKA activity [46]. Mutation analysis with the BDNF
promoter IV has identified a CRE-like sequence 59-TCACGTCA-
39 (termed as B-CRE or CaRE3) [21,24,47]. It has been shown
that endogenous CREB binds CaRE3 sequence in vitro and in vivo
[21,26,47]. Importantly, genetic mutation of the CaRE3 sequence
in mice disrupted activity-dependent up-regulation of BDNF
transcription [26]. Although the full-scale activation of CaRE3
and CRE by Ca
2+ requires the same protein kinases, the difference
in nucleotide sequence between them may recruit different
transcription complexes. Indeed, this possibility is supported by
that inhibition of PKA abolished CaRE3 activation but allowed
partial CRE activation by Ca
2+.
CREB activity could be regulated by multiple Ca
2+-stimulated
protein kinases. It has been demonstrated that phosphorylation of
CREB at Ser-133 facilitates the recruitment of coactivator CBP
(CREB binding protein) [48], which is critical for CREB-mediated
transcription [49]. Activation of CaMKII, CaMKIV and
ERK1/2 may all lead to CREB phosphorylation at Ser-133
[27,50,51,52,53]. Supportively, CaMKIV activity is required for
CaRE3/CRE-mediated transcription. However, inhibition of
CaMKII has no effect on CaRE3/CRE activity. It may be due
to the CaMKII-mediated phosphorylation of CREB at Ser-142,
which antagonizes CREB-mediated transcription [53]. Moreover,
overexpression of constitutively active CaMKI causes the
activation of CREB [53]. Intriguingly, we found that dnCaMKI
suppressed NMDAR- but not L-VGCC-mediated CRE and
CaRE3 activity. It has been demonstrated that NMDAR-
mediated ERK1/2 activation requires the CaMKK-CaMKI
cascade [36]. Because the ERK1/2-mediated activation of
RSK2 and MSK1 may lead to phosphorylation of CREB at
Ser-133 [27,51,52], dnCaMKI may suppress CREB activity and
CRE/CaRE3-mediated transcription through the ERK1/2-
RSK2/MSK1 cascade in NMDA-stimulated neurons.
The crosstalk among Ca
2+-stimulated protein kinases expands
beyond the interaction between CaMKI and ERK1/2. For
example, PKA activity may directly regulate Ser-133 phosphor-
ylation of CREB, or indirectly through ERK1/2-RSK2 [54]. On
one hand, cAMP elevation and PKA may up-regulate ERK1/2
through RAP [55]. On the other hand, PKA activity is also
required for nuclear translocation of ERK1/2 [27]. Further,
calcium activation of Ras-ERK1/2 cascade may directly regulate
PI3K [56]. Also, PI3K may be up-stream of ERK1/2 activation,
as indicated in vivo during memory retrieval [28]. During the
induction of long-term synaptic potentiation, PI3K also affects
high frequency stimulation-induced ERK1/2 activation [57].
Consistent with these previous studies, our data showed that
PI3K, PKA, and CaMKs activity impinged on ERK1/2
activation. To add another layer of complication, blocking
CaMKs fully abolished the L-VGCC-mediated PIV activation.
It is possible that CaMKs affect a broader spectrum of other
signaling pathways (in addition to ERK1/2). Alternatively, some
Figure 10. Crosstalk among calcium-stimulated protein kinases
and the effects of simultaneous inhibition on promoter IV-
mediated transcription. DIV 14 neurons were treated with KN93, or
LY294002, or H89 for 30 min before the KCl (50 mM) stimulation. The
level of phospho-ERK1/2 and b-actin were examined 20 min after the
stimulation by Western blot (A). The signal of pERK1/2 was quantified
and normalized to b-actin (B). In the right panel of B, the effects of
protein kinase inhibitors on KCl-induced pERK1/2 up-regulation were
normalized to the pERK1/2 level in neurons treated with inhibitor only
(*: statistically different to that of KCl-stimulated pERK1/2 up-regulation
in neurons not treated with protein kinase inhibitors). In C, neurons
were transfected with PIV-Luc and TK-pRL on DIV 9. On DIV 11, neurons
were first treated with PD98059 (PD), LY294002 (LY), H89, and KN93
individually, or a combination of PD+LY, PD+H89, and PD+LY+KN+H89
(Cocktail) for 30 minutes. Then neurons were stimulated with KCl along
with CNQX and APV for 6 hours, and analyzed by luciferase assay.
Another set of neurons receiving inhibitor treatment without KCl was
used for normalization purposes. The relative up-regulation of PIV
activity in neurons treated with KCl+inhibitor was normalized to the
PIV-luciferase level in neurons treated with inhibitor only. *: statistically
different to that of KCl-stimulated PIV activity in neurons not treated
with any inhibitor. #: significant different to KCl-stimulated PIV activity
in neurons treated with either PD or LY. $: significant different to KCl-
stimulated PIV activity in neurons treated with either H89 or PD. ns: not
significantly different. Data were collected from 4 independent
preparations for each treatment.
doi:10.1371/journal.pone.0028441.g010
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control the sequential steps involved in transcriptional up-
regulation.
Because the cAMP-stimulated exon IV transcription is not as
robust as Ca
2+-stimulated transcription, it has been hypothesized
that additional cis-elements other than CRE may exist in PIV.
Indeed, a neurospecific protein CaRF was identified to regulate L-
VGCC-mediated CaRE1 activity [24]. Although sequence analysis
of CaRF implicates potential phosphorylationtarget sites of ERK1/
2 and CaMKII [24], how these protein kinases regulate CaRE1-
mediated transcription and CaRF activity is unknown. Here, we
report that Ca
2+-stimulated CaRE1 activations through L-VGCC
or NMDAR are mechanistically different. Our data also showed
that CaRE1 activity is independent of CREB. Furthermore, we
found that the regulation of CaRF activity was different from
CaRE1-mediated transcription. Supportively, a previous study
showed that loss of CaRF did not fully phenocopy the mutation of
CaRE1 [24,58], suggesting that additional CaRE1 binding protein
may exist. Further, it is possible that there are additional
mechanisms to regulate the binding of CaRF to CaRE1.
How do CaRE1 and CaRE3 coordinate to regulate PIV
activity? Mutation or deletion of either CaRE1 or CaRE3 ablates
Ca
2+-stimulated up-regulation of PIV activity [21,24]. This
indicates that activation of CaRE1 or CaRE3 alone in the context
of flanking sequences of PIV is not sufficient to drive exon IV
transcription. Our results are consistent with this possibility, and
suggest that coordination and crosstalk between CaRE1 and
CaRE3 may be required for the full activity of PIV. This is
supported by that blocking either CaRE1 or CaRE3 activity with
certain kinase inhibitor (for example, PKA in NMDA-stimulated
neurons) inhibits promoter IV activity.
In summary, we systematically examined the function of the
major Ca
2+-stimulated CREB/CaRF kinases. We found that,
depending on the route of calcium entry, CaRE1 and CaRE3
were differentially regulated by different protein kinases. Based on
our results and the previous studies, we propose a working model
to show how crosstalk between different signaling cascades and
coordination of multiple CaREs regulate the activity-dependent
transcription of BDNF (Figure 11).
Supporting Information
Figure S1 BDNF IV mRNA stability is not affected by
KCl/NMDA stimulation or inhibition of the protein
kinases. DIV 14 neurons were incubated with transcription
inhibitor actinomycin D (ACD, at 100 ng/ml) before treatment
Figure 11. L-VGCC- and NMDAR-mediated activation of CaRE1 and CaRE3/CRE are differentially regulated. Depending on the route of
Ca
2+ entry, different Ca
2+-stimulated protein kinases are required for L-VGCC- (A) and NMDAR-mediated (B) transcriptional up-regulation of BDNF
exon IV. The activation of the major calcium responsive elements, CaRE1 and CaRE3/CRE, also require different signaling molecules. The functional
molecules in the Ca
2+-triggered signaling cascade are connected by arrows pointing from up-stream regulators to down-stream targets. For both (A)
and (B), protein kinases in the white boxes are required for CaRE1 activation. Protein kinases in the green boxes are required for CaRE3/CRE activation.
Protein kinases in the yellow boxes are required for the activation of both CaRE1 and CaRE3/CRE. Therefore, the changing of box colors for a specific
molecule between (A) and (B) indicates the different mechanism underlying L-VGCC- and NMDAR-mediated transcription. For (A), the signaling
molecules written in red are those required for CaRF activation. Therefore, based on the color of the box and the color of the word, the regulatory
difference between CaRE1 and CaRF could be discriminated. For (B), the ‘‘?’’ indicates that the transcription factors need to be identified for NMDAR-
mediated CaRE1 activation.
doi:10.1371/journal.pone.0028441.g011
Regulation of BDNF Transcription by Ca
2+
PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e28441with PD98059, LY294002, H89, KN93, 50 mM KCl, or 20 uM
NMDA. Real-time PCR was performed to measure BDNF IV
mRNA, which was then normalized to GAPDH. No significance
wasdetected between thetreatedgroup andthecontrolgroup.Data
were collected from 8 independent preparations for each treatment.
(TIF)
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